Plasma proteomics reveals novel protein signatures associated with dementia in chronic pain individuals: a prospective cohort study

Abstract

Background: The relationship between chronic pain and Alzheimer’s disease (AD) remains poorly understood, despite growing evidence suggesting shared molecular pathways. Mass spectrometry‐based proteomics enables simultaneous analysis of thousands of proteins with high precision, providing advantages over traditional targeted methods.